ALS is now in the final stages of developing new real-time polymerase chain reaction (PCR) test kits for detection of the COVID-19 virus in human and on surface samples. Currently, human samples are collected by medical professionals and tested using commercially available kits in ALS’ existing Life Sciences laboratory facilities with a turnaround time of approximately 5 hours.
Surfaces swabs follow a similar process and are used to validate hygiene procedures in place to control the spread of COVID-19 across a wide range of clients’ operating sites and other infrastructure.
These services are being offered in Portugal and are being expanded across ALS’ Life Sciences global network where opportunities exist including Asia, Australia, Canada, Europe, Latin America, UK, and the USA.
ALQ Price at posting:
$6.37 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)